A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
Public ClinicalTrials.gov record NCT05014438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blinded, Placebo-controlled, 5 Parallel-group Study of BMS-986166 or Branebrutinib for the Treatment of Patients With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT05014438
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Interventions
- BMS-986166 Drug
- Branebrutinib Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 16, 2021
- Primary completion
- Aug 21, 2022
- Completion
- Aug 21, 2022
- Last update posted
- Oct 17, 2023
2021 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0091 | Fremont | California | 94538 | — |
| Local Institution - 0112 | Brandon | Florida | 33511 | — |
| Local Institution - 0061 | Coral Gables | Florida | 33134 | — |
| Local Institution - 0110 | Margate | Florida | 33063 | — |
| Local Institution - 0006 | Miami Lakes | Florida | 33014 | — |
| Local Institution | Tampa | Florida | 33613 | — |
| Local Institution - 0008 | Skokie | Illinois | 60077 | — |
| Local Institution - 0081 | Indianapolis | Indiana | 46250 | — |
| Local Institution - 0083 | Louisville | Kentucky | 40217 | — |
| Dermatology and Skin Cancer Specialists, LLC | Rockville | Maryland | 20850 | — |
| Local Institution - 0051 | Saint Joseph | Missouri | 64506 | — |
| Local Institution | New York | New York | 10029 | — |
| Local Institution - 0078 | Philadelphia | Pennsylvania | 19103 | — |
| Local Institution - 0094 | Pittsburgh | Pennsylvania | 15213 | — |
| The University of Texas Health Science Center at Houston | Bellaire | Texas | 77401 | — |
| Local Institution | San Antonio | Texas | 78213 | — |
| Local Institution - 0003 | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05014438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05014438 live on ClinicalTrials.gov.